Clinical Trials in New York State

Showing 5001-5020 of 13,041 trials

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

NCT04476472

Subjects will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 94-day (13-week) hybrid closed-loop phase conducted in an outpatient setting, and an optional 12-month extension phase.

Type 1 Diabetes Mellitus

Insulet Corporation80 participantsStarted Sep 2020

Palo Alto, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +7 more locations

COMPLETEDPhase 392 miles

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

NCT04143217

Open label, flexible dose, long-term multicenter study of safety and efficacy of SPN-812 in adult ADHD patients

Attention-Deficit/Hyperactivity Disorder

Supernus Pharmaceuticals, Inc.159 participantsStarted Jan 2020

Beverly Hills, California, United States • Garden Grove, California, United States • Los Alamitos, California, United States +35 more locations

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Find Trials by Condition in New York State

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

Registry of CytoSorb Therapy in COVID-19 ICU Patients

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

Practice of Acceptance, Awareness, and Compassion in Caregiving (PAACC)

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

Lung EpiCheck Biomarkers Development Study

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis